The Drug Controller General of India authorized the country’s first nasal spray vaccine "under Restricted Use in Emergency Situations for ages 18 and above," marking a big step toward increasing the availability of needle-free vaccines around the world. Washington University St. Louis, which had created and developed the recombinant adenoviral...